HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models.

Abstract
Given the rising prevalence of lipid metabolic disorders and malignant diseases, we aimed to establish an in vivo hypercholesterinaemic tumour-bearing rat model for the induction and assessment of these conditions. A normal standard CRLT/N, 2 (baseline),- or 4 (2 + 2, pretreated)-week-long butter and cholesterol rich (BCR) diet was applied to mesoblastic nephroma (Ne/De) and myelomonoblastic leukaemia (My1/De) tumour-bearing and healthy control Long—Evans and Fischer 344 rats. The beginning of chow administration started in parallel with tumour induction and the 2 weeks of pre-transplantation in the baseline and pretreated groups, respectively. Fourteen days post-inoculation, the measurement of lipid parameters and [18F]F-FDG PET/MRI examinations was executed. The comparable lipid status of baseline healthy and tumorous rats proves that regardless of tumour presence, BCR-based hypercholesterolemia was achieved. A higher tumour mass among pretreated tumorous animals was found when compared to the control groups (p < 0.05, p < 0.01). Further, a visually greater [18F]F-FDG accumulation was observed in pretreated BCR tumorous animals; however, the quantitative data (SUVmean: 9.86 ± 0.98, 9.68 ± 1.24; SUVmax: 19.63 ± 1.20; 17.56 ± 3.21 for Ne/De and My1/De, respectively) were not statistically significantly different from those of the CRLT/N tumorous rats (SUVmean: 8.40 ± 1.42, 7.22 ± 1.06 and SUVmax: 15.99 ± 2.22, 12.46 ± 1.96 for control Ne/De and My1/De, respectively). Our model seems to be appropriate for simultaneously investigating hypercholesterolemia and cancer in the same rat.
AuthorsZita Képes, Alexandra Barkóczi, Judit P Szabó, Ibolya Kálmán-Szabó, Viktória Arató, Ildikó Garai, Péter Árkosy, István Jószai, Ádám Deák, István Kertész, István Hajdu, György Trencsényi
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 23 Issue 21 (Oct 27 2022) ISSN: 1422-0067 [Electronic] Switzerland
PMID36361850 (Publication Type: Journal Article)
Chemical References
  • Fluorodeoxyglucose F18
  • Lipids
  • Radiopharmaceuticals
Topics
  • Animals
  • Rats
  • Fluorodeoxyglucose F18
  • Nephroma, Mesoblastic
  • Hypercholesterolemia
  • Rats, Long-Evans
  • Positron-Emission Tomography
  • Kidney Neoplasms (diagnostic imaging)
  • Leukemia
  • Lipids
  • Radiopharmaceuticals
  • Positron Emission Tomography Computed Tomography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: